Stocktoria

Milestone Pharmaceuticals Inc. MIST

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-05-09

Milestone Pharmaceuticals Inc. statistics & valuation

Market cap$154.4M
P / B3.7×
Return on equity-151.0%
Net cash$15.9M
Enterprise value USD$138.5M
Earnings yield EBIT/EV-44.9%
Return on capital-62.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
20182019202020212022202320242025
Return on equity (%)
-27.80% -48.10% -34.90% -38.10% -88.00% -355.90% -315.80% -151.00% 20182019202020212022202320242025
Shares outstanding
596787 24.5M 29.8M 29.9M 34.3M 33.5M 53.4M 106.2M 20182019202020212022202320242025
Net debt ($)
-$119.8M $36.0M $28.0M -$15.9M 20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-26.30% -44.70% -33.30% -35.80% -78.40% -79.30% -55.00% -55.50% 20182019202020212022202320242025
Free cash flow margin (%)
20182019202020212022202320242025
Debt / equity (×)
0.00× 2.97× 4.06× 1.37× 20182019202020212022202320242025
EPS ($)
-$1.70 -$1.02 -$1.38 -$1.39 -$0.67 -$0.75 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Return on assets-55.5%-55.0%-79.3%-78.4%-35.8%-33.3%-44.7%-26.3%
Return on equity-151.0%-315.8%-355.9%-88.0%-38.1%-34.9%-48.1%-27.8%
Debt / equity1.37×4.06×2.97×———0.00×—
Current ratio8.019.1010.1111.7017.5524.1414.7119.42

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.